Stocklytics Platform
Asset logo for symbol CNMD
Asset logo for symbol CNMD



AI Deep-Learning Forecast (CNMD)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

CONMED (CNMD) Stocklytics Forecast

CONMED Corp (CNMD) is a medical technology company that specializes in surgical devices and equipment. The company has a strong track record of innovation and has developed a wide range of cutting-edge products for use in various surgical procedures. As a leading player in the industry, CONMED Corp has a solid foundation and is well-positioned for future growth.

When it comes to predicting the stock price of CONMED Corp (CNMD), there are several factors to consider. One important factor is the company's financial performance. By analyzing the company's historical financial data, investors can gain insights into its past performance and make informed predictions about its future prospects. Additionally, market trends and industry outlooks can also provide valuable information for predicting the stock price of CNMD.

add CONMED to watchlist

Keep an eye on CONMED

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

What is the analyst price prediction for CONMED (CNMD) stock?

Analysts have set a target price of $122.77 for CONMED (CNMD), based on forecasts from 30 analysts. The predicted price range extends from a high of $155 to a low of $85. This represents a potential increase of up to 118.43% and a decrease of 19.79% from the current price of $70.96. These forecasts are as of 2022 May 05.

What are the analyst ratings for CONMED (CNMD) stock?

The analyst ratings for CONMED (CNMD) are distributed as follows: 2 analysts recommend buying, 4 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 6 analysts leans towards a neutral rating. These ratings indicate the general sentiment among the analysts covering CONMED.

What is the AI price prediction for CONMED (CNMD) stock?

At present, there is no AI or machine-learning-based price prediction available for CONMED (CNMD) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.


Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level